Patent Appeal Goes Against U. of Rochester

A federal appeals court has reaffirmed a lower court's invalidation of a drug patent held by the University of Rochester, dealing another blow to the university's legal battle to collect billions of dollars from the pharmaceutical company that makes the popular painkiller Celebrex.

In a unanimous decision, a three-judge panel of the U.S. Court of Appeals for the Federal Circuit, in Washington, agreed with the U.S. District Court in Rochester, N.Y., that the patent was too general to

Digital or Print Subscription

Already have an account? Log In Now.